Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cerebral cavernous malformations: mutations in Krit1.

D J Verlaan1, W J Davenport, H Stefan

  • 1Center for Research in Neurosciences, Montreal General Hospital, McGill University, Montreal, Quebec, Canada.

Neurology
|March 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Posttranslational modifications & lithium's therapeutic effect-Potential biomarkers for clinical responses in psychiatric & neurodegenerative disorders.

Neuroscience and biobehavioral reviews·2021
Same author

Alpha galactosidase A activity in Parkinson's disease.

Neurobiology of disease·2018
Same author

Rare susceptibility variants for bipolar disorder suggest a role for G protein-coupled receptors.

Molecular psychiatry·2017
Same author

Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia.

Translational psychiatry·2017
Same author

Correction: ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.

The Journal of experimental medicine·2017
Same author

Neurons derived from patients with bipolar disorder divide into intrinsically different sub-populations of neurons, predicting the patients' responsiveness to lithium.

Molecular psychiatry·2017
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Mutations in the Krit1 gene are found in 47% of families with cerebral cavernous malformations (CCM). These Krit1 mutations, identified in novel upstream exons, suggest a role in CCM development, potentially as a tumor suppressor gene.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Cerebral cavernous malformations (CCM) are vascular abnormalities in the brain.
  • The CCM1 gene, also known as Krit1, is implicated in CCM development.
  • Novel exons in the Krit1 gene have been recently identified.

Purpose of the Study:

  • To identify mutations in the additional exons of the Krit1 gene associated with CCM1.
  • To determine the frequency of Krit1 mutations in CCM patients.
  • To recharacterize previously reported Krit1 mutations.

Main Methods:

  • Screening of 27 families and 11 sporadic individuals for Krit1 mutations.
  • Utilizing single-stranded conformation polymorphism (SSCP) for mutation detection.
  • Sequencing of identified variants and familial segregation analysis.

Related Experiment Videos

Main Results:

  • Identified two new mutations in novel upstream exons of Krit1.
  • Discovered six additional mutations in previously known exons of Krit1.
  • Found no Krit1 mutations in sporadic CCM individuals.

Conclusions:

  • Krit1 mutations account for 47% of familial CCM cases studied.
  • Mutations are distributed throughout the Krit1 gene, not confined to specific domains.
  • Findings support the hypothesis that Krit1 functions as a tumor suppressor gene.